P19-50 LB. Role of vaccine-induced innate and adaptive immunity in controlling mucosal transmission of SIV in macaques
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1742-4690
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
P19-50 LB. Role of vaccine-induced innate and adaptive immunity in controlling mucosal transmission of SIV in macaques ; volume:6 ; number:3 ; day:22 ; month:10 ; year:2009 ; pages:1 ; date:10.2009
Retrovirology ; 6, Heft 3 (22.10.2009), 1, 10.2009
- Creator
-
Sui, Y.
- Contributor
-
Zhu, Q.
Gagnon, S.
Dzutsev, A.
Terabe, M.
Vaccari, M.
Venzon, D.
Klinman, D.
Strober, W.
Kelsall, B.
Franchini, G.
Belyakov, IM
Berzofsky, JA
SpringerLink (Online service)
- DOI
-
10.1186/1742-4690-6-S3-P414
- URN
-
urn:nbn:de:1111-201608078616
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 11:01 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Sui, Y.
- Zhu, Q.
- Gagnon, S.
- Dzutsev, A.
- Terabe, M.
- Vaccari, M.
- Venzon, D.
- Klinman, D.
- Strober, W.
- Kelsall, B.
- Franchini, G.
- Belyakov, IM
- Berzofsky, JA
- SpringerLink (Online service)
Other Objects (12)
P19-24. Evaluation of recombinant influenza-SIV vaccines in macaques
Mucosal T follicular helper cells in SIV-infected rhesus macaques: contributing role of IL-27
P11-19. Altered mucosal distribution of SIV-specific T cells in Rhesus macaques infected with the live-attenuated Rev-independent SIV
P19-46. Co-delivery of mucosal chemokine plasmids in a systemically delivered DNA vaccine elicits systemic and mucosal immune responses in mice and macaques
Increased neutrophil apoptosis in chronically SIV-infected macaques
P19-57 LB. Gene-based vaccination protects against mucosal infection by a heterologous highly pathogenic SIV isolate in rhesus monkeys
P19-35. Replicating adenovirus type 5 host range recombinant vaccine biodistribution in rhesus macaques following multiple mucosal routes of immunization
Strong mucosal immune responses in SIV infected macaques contribute to viral control and preserved CD4+ T-cell levels in blood and mucosal tissues
Effect of early anti-retroviral therapy on the pathogenic changes in mucosal tissues of SIV infected rhesus macaques
Mucosal-associated invariant T (MAIT) cells provide B-cell help in vaccinated and subsequently SIV-infected Rhesus Macaques
P19-02. High protection of female macaques from repeated intravaginal challenges with SHIV-162P3 upon mucosal vaccination with Gp41 subunits-virosomes
IL-2 immunotherapy in chronically SIV-infected Rhesus Macaques
P19-24. Evaluation of recombinant influenza-SIV vaccines in macaques
Mucosal T follicular helper cells in SIV-infected rhesus macaques: contributing role of IL-27
P11-19. Altered mucosal distribution of SIV-specific T cells in Rhesus macaques infected with the live-attenuated Rev-independent SIV
P19-46. Co-delivery of mucosal chemokine plasmids in a systemically delivered DNA vaccine elicits systemic and mucosal immune responses in mice and macaques
Increased neutrophil apoptosis in chronically SIV-infected macaques
P19-57 LB. Gene-based vaccination protects against mucosal infection by a heterologous highly pathogenic SIV isolate in rhesus monkeys
P19-35. Replicating adenovirus type 5 host range recombinant vaccine biodistribution in rhesus macaques following multiple mucosal routes of immunization
Strong mucosal immune responses in SIV infected macaques contribute to viral control and preserved CD4+ T-cell levels in blood and mucosal tissues
Effect of early anti-retroviral therapy on the pathogenic changes in mucosal tissues of SIV infected rhesus macaques
Mucosal-associated invariant T (MAIT) cells provide B-cell help in vaccinated and subsequently SIV-infected Rhesus Macaques
P19-02. High protection of female macaques from repeated intravaginal challenges with SHIV-162P3 upon mucosal vaccination with Gp41 subunits-virosomes
IL-2 immunotherapy in chronically SIV-infected Rhesus Macaques
P19-24. Evaluation of recombinant influenza-SIV vaccines in macaques
Mucosal T follicular helper cells in SIV-infected rhesus macaques: contributing role of IL-27
P11-19. Altered mucosal distribution of SIV-specific T cells in Rhesus macaques infected with the live-attenuated Rev-independent SIV
P19-46. Co-delivery of mucosal chemokine plasmids in a systemically delivered DNA vaccine elicits systemic and mucosal immune responses in mice and macaques
Increased neutrophil apoptosis in chronically SIV-infected macaques
P19-57 LB. Gene-based vaccination protects against mucosal infection by a heterologous highly pathogenic SIV isolate in rhesus monkeys
P19-35. Replicating adenovirus type 5 host range recombinant vaccine biodistribution in rhesus macaques following multiple mucosal routes of immunization
Strong mucosal immune responses in SIV infected macaques contribute to viral control and preserved CD4+ T-cell levels in blood and mucosal tissues
Effect of early anti-retroviral therapy on the pathogenic changes in mucosal tissues of SIV infected rhesus macaques
Mucosal-associated invariant T (MAIT) cells provide B-cell help in vaccinated and subsequently SIV-infected Rhesus Macaques
P19-02. High protection of female macaques from repeated intravaginal challenges with SHIV-162P3 upon mucosal vaccination with Gp41 subunits-virosomes